2020
DOI: 10.1007/s10067-020-05108-1
|View full text |Cite
|
Sign up to set email alerts
|

Genetic panel screening in patients with clinically unclassified systemic autoinflammatory diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
9
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 29 publications
3
9
0
1
Order By: Relevance
“…This rate supports other studies focusing on the genetic diagnosis of AID [5,13,[36][37][38][39][40][41]. Cohorts of equal size [5,13,36] and larger cohorts [41] were both evaluated in these studies, and some only included pediatric patients [12,39,42,43], while others also included adults [36-38, 41, 44, 45]. A higher positive yield was reported in studies with a more selective choice in the patient cohort, e.g.…”
Section: Discussionsupporting
confidence: 84%
See 2 more Smart Citations
“…This rate supports other studies focusing on the genetic diagnosis of AID [5,13,[36][37][38][39][40][41]. Cohorts of equal size [5,13,36] and larger cohorts [41] were both evaluated in these studies, and some only included pediatric patients [12,39,42,43], while others also included adults [36-38, 41, 44, 45]. A higher positive yield was reported in studies with a more selective choice in the patient cohort, e.g.…”
Section: Discussionsupporting
confidence: 84%
“…In addition, we identified in 43.2% VUS, which could become clinically relevant in the future. This rate supports other studies focusing on the genetic diagnosis of AID [5,13,[36][37][38][39][40][41]. Cohorts of equal size [5,13,36] and larger cohorts [41] were both evaluated in these studies, and some only included pediatric patients [12,39,42,43], while others also included adults [36-38, 41, 44, 45].…”
Section: Discussionsupporting
confidence: 83%
See 1 more Smart Citation
“…The larger cohorts of patients came from the international Eurofever registry, Japan and Middle East [ 16 , 19 , 21 ]. The median ages at the symptoms onset and patient enrollment are 13 (±13) and 25 (±18) years, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…The median ages at the symptoms onset and patient enrollment are 13 (±13) and 25 (±18) years, respectively. In the four pediatric studies, the median diagnosis delay was 35 months (range 13–78) [ 5 , 19 , 22 , 23 ]. Males are 42% of the total.…”
Section: Resultsmentioning
confidence: 99%